1 follower
Dyve is a clinical-stage biotech company with its lead asset, DYV700, currently completing a 20-center, 100-patient, Phase 2 clinical study for the treatment of acute gout.
Tessera Therapeutics
2 followers
89bio
2 followers
Kyverna Therapeutics
7 followers
Ventyx Biosciences
1 follower
Longeveron
1 follower
Astria Therapeutics
1 follower
ADARx Pharmaceuticals
3 followers
Thermo Fisher Scientific
179 followers
Genentech
161 followers
Gilead Sciences
136 followers
Regeneron
104 followers
Explore companies